NFE2L2 and Alzheimer disease: Nevertheless, Nrf2 activation strategies hold tremendous translational potential, not only because they target two of the most fundamental pathological mechanisms in AD, but also because some compounds are already in clinical stages, offering the possibility of viable treatments for the disease in the near future.